Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Davide Rossi |
| Publication date | November 16, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://ashpublications.org/blood/article/120/21/200/85572/Overall-Survival-Benefit-for |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |